Viewing StudyNCT06479356



Ignite Creation Date: 2024-07-17 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06479356
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2024-06-24

Brief Title: CD19-targeted CAR T Cells for Relapsed or Refractory RR Large B-cell Lymphoma
Sponsor: Shanghai Ming Ju Biotechnology Co Ltd
Organization: Shanghai Ming Ju Biotechnology Co Ltd

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08-31
Start Date Type: ESTIMATED
Primary Completion Date: 2025-04-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-06-24
First Submit QC Date: None
Study First Post Date: 2024-06-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-19
Last Update Post Date: 2024-06-28
Last Update Post Date Type: ACTUAL